Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nociceptive neuron sodium channels refer principally to subtypes of voltage-gated sodium channels—Naᵥ1.7, Naᵥ1.8, and Naᵥ1.9—expressed predominantly in primary sensory neurons called nociceptors. These channels are essential for the initiation and propagation of action potentials in response to noxious (painful) stimuli and play key roles in encoding peripheral pain signals. Naᵥ1.7 acts as a threshold channel for pain signal initiation, Naᵥ1.8 supports the rapid action potential upstroke in nociceptors, and Naᵥ1.9 modulates subthreshold excitability and resting membrane potential[1][3][4]. Gain- or loss-of-function mutations in these channels can produce rare human pain syndromes. Targeting these channels is a major therapeutic strategy for pain management, with ongoing development of subtype-selective inhibitors[3]. These channels are part of the broader family of VGSCs, which have nine known mammalian α subunit isoforms, each encoded by distinct SCN genes[1][3][4]. The name "nociceptive neuron sodium channel" is non-specific and does not correctly refer to a unique protein or gene. For structured data or scientific use, a precise channel subtype (e.g., "Sodium channel protein type 7 subunit alpha" for Naᵥ1.7, encoded by SCN9A) should be specified[1][3]. Multiple subtypes may be relevant in any single context, and their roles sometimes overlap or are compensatory in sensory neurons[1][3][4].
Blockade of sodium influx to inhibit action potential initiation and conduction; Inhibition of channel activation or modulation of gating properties
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium channel protein type 7 subunit alpha (Naᵥ1.7), Sodium channel protein type 8 subunit alpha (Naᵥ1.8), Sodium channel protein type 9 subunit alpha (Naᵥ1.9) (Naᵥ1.7, Naᵥ1.8, Naᵥ1.9).